Who is sponsoring NCT01774591?

NCT01774591 is sponsored by University of Chicago.

What condition does NCT01774591 study?

NCT01774591 studies Hypertension.

What drugs are being tested in NCT01774591?

Interventions: Azilsartan medoximil, Placebo.

What is the status of NCT01774591?

NCT01774591 is currently COMPLETED.

Last reviewed 2017-10-10 · How we verify

Effect of Azilsartan on Aldosterone in Postmenopausal Females

NCT01774591 NA COMPLETED Results posted

The purpose of the research is to evaluate the effect of azilsartan medoximil on blood pressure and urinary aldosterone levels in postmenopausal females.

Details

Lead sponsor	University of Chicago
Phase	NA
Status	COMPLETED
Enrolment	21
Start date	2013-01
Completion	2016-01

Conditions

Hypertension

Interventions

Azilsartan medoximil
Placebo

Primary outcomes

24-hour BP (Systolic) — 26 weeks
To evaluate the effect of an angiotensin receptor blocker (azilsartan medoximil) on blood pressure in postmenopausal females.
24-hour BP (Diastolic) — 26 weeks
To evaluate the effect of an angiotensin receptor blocker (azilsartan medoximil) on blood pressure in postmenopausal females.

Countries

United States